|
MAP7D3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.34550000030487E-07 |
| Normal-vs-Stage3 |
1.51879619991746E-11 |
| Normal-vs-Stage4 |
3.99991151311951E-12 |
| Stage1-vs-Stage2 |
2.109400E-01 |
| Stage1-vs-Stage3 |
5.222400E-01 |
| Stage1-vs-Stage4 |
6.472800E-01 |
| Stage2-vs-Stage3 |
5.183000E-01 |
| Stage2-vs-Stage4 |
1.634780E-01 |
| Stage3-vs-Stage4 |
3.942200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
4.71280000002849E-06 |
| Normal-vs-Asian |
2.877600E-03 |
| Caucasian-vs-AfricanAmerican |
5.234500E-02 |
| Caucasian-vs-Asian |
2.807200E-01 |
| AfricanAmerican-vs-Asian |
8.152200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.67499347725197E-12 |
| Male-vs-Female |
5.403600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.756720E-04 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(81-100Yrs) |
8.434800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.917900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.843600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.421600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.360600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.520800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.644200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.158860E-03 |
| Normal-vs-Grade 2 |
1.6242562850266E-12 |
| Normal-vs-Grade 3 |
1.11022302462516E-16 |
| Normal-vs-Grade 4 |
4.48000000430326E-08 |
| Grade 1-vs-Grade 2 |
5.953800E-01 |
| Grade 1-vs-Grade 3 |
5.109600E-01 |
| Grade 1-vs-Grade 4 |
1.691780E-01 |
| Grade 2-vs-Grade 3 |
6.669600E-01 |
| Grade 2-vs-Grade 4 |
5.970200E-02 |
| Grade 3-vs-Grade 4 |
1.331430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
6.77746747612673E-12 |
| ccA subtype-vs-ccB subtype |
3.443100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62470037423645E-12 |
| Normal-vs-N1 |
3.746000E-02 |
| N0-vs-N1 |
4.301600E-01 |
|
|
